Your browser doesn't support javascript.
loading
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity.
Nielsen, Stine Sf; Vibholm, Line K; Monrad, Ida; Olesen, Rikke; Frattari, Giacomo S; Pahus, Marie H; Højen, Jesper F; Gunst, Jesper D; Erikstrup, Christian; Holleufer, Andreas; Hartmann, Rune; Østergaard, Lars; Søgaard, Ole S; Schleimann, Mariane H; Tolstrup, Martin.
Afiliação
  • Nielsen SS; Department of Infectious Diseases, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark.
  • Vibholm LK; Department of Infectious Diseases, Aarhus University Hospital, Denmark.
  • Monrad I; Department of Infectious Diseases, Aarhus University Hospital, Denmark.
  • Olesen R; Department of Infectious Diseases, Aarhus University Hospital, Denmark.
  • Frattari GS; Department of Infectious Diseases, Aarhus University Hospital, Denmark.
  • Pahus MH; Department of Clinical Medicine, Aarhus University, Denmark.
  • Højen JF; Department of Infectious Diseases, Aarhus University Hospital, Denmark.
  • Gunst JD; Department of Infectious Diseases, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark.
  • Erikstrup C; Department of Clinical Immunology, Aarhus University Hospital, Denmark.
  • Holleufer A; Department of Molecular Biology and Genetics, Aarhus University, Denmark.
  • Hartmann R; Department of Molecular Biology and Genetics, Aarhus University, Denmark.
  • Østergaard L; Department of Infectious Diseases, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark.
  • Søgaard OS; Department of Infectious Diseases, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark.
  • Schleimann MH; Department of Infectious Diseases, Aarhus University Hospital, Denmark.
  • Tolstrup M; Department of Infectious Diseases, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark.
EBioMedicine ; 68: 103410, 2021 Jun.
Article em En | MEDLINE | ID: mdl-34098342
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / Enzima de Conversão de Angiotensina 2 / SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: EBioMedicine Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / Enzima de Conversão de Angiotensina 2 / SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: EBioMedicine Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca